Table 5.
Enteral tube feeding (ETF) practices (none, nasogastric tube [NGT] only or gastrostomy tube after NGT) before and after 2009, by the type of inherited disease (N = 190).
| n (%) | No ETF (N = 92) | NGT only (N = 63) | Gastrostomy (N = 35) | P-value |
|---|---|---|---|---|
| Organic aciduria | ||||
| Before 2009 | 15 (33.3) | 20 (44.5) | 10 (22.2) | 0.930 |
| After 2009 | 5 (33.3) | 6 (40.0) | 4 (26.7) | |
| Urea cycle disorder | ||||
| Before 2009 | 30 (79.0) | 5 (13.2) | 3 (7.8) | 0.458 |
| After 2009 | 13 (76.5) | 1 (5.8) | 3 (17.7) | |
| Maple syrup urine disease | ||||
| Before 2009 | 14 (66.7) | 5 (23.8) | 2 (9.5) | 0.840 |
| After 2009 | 9 (81.8) | 2 (18.2) | 0 | |
| Glycogen storage disease | ||||
| Before 2009 | 2 (11.8) | 11 (64.7) | 4 (23.5) | 0.704 |
| After 2009 | 1 (11.2) | 4 (44.4) | 4 (44.4) | |
| Fatty acid oxidation deficiency | ||||
| Before 2009 | 1 (9.1) | 7 (63.6) | 3 (27.3) | 0.440 |
| After 2009 | 2 (33.4) | 2 (33.3) | 2 (33.3) | |
| All patients | ||||
| Before 2009 | 62 (47.0) | 48 (36.4) | 22 (16.6) | 0.325 |
| After 2009 | 30 (51.7) | 15 (25.9) | 13 (22.4) |
P-value of Chi-2 test (for all patients) or Fisher's exact test (for each disease).